Cromer Finance Ltd. v. Berger

245 F. Supp. 2d 552, 2003 U.S. Dist. LEXIS 2249, 2003 WL 355440
CourtDistrict Court, S.D. New York
DecidedFebruary 18, 2003
Docket00 Civ. 2284(DLC)
StatusPublished
Cited by7 cases

This text of 245 F. Supp. 2d 552 (Cromer Finance Ltd. v. Berger) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Cromer Finance Ltd. v. Berger, 245 F. Supp. 2d 552, 2003 U.S. Dist. LEXIS 2249, 2003 WL 355440 (S.D.N.Y. 2003).

Opinion

OPINION AND ORDER

COTE, District Judge.

Plaintiffs Cromer Finance Ltd. (“Cromer”) and Prival N.V. (“Prival”) (collectively, the “Cromer Plaintiffs”) filed this securities class action complaint on March 24, 2000. The plaintiffs were investors in an off-shore investment fund, the Manhattan Investment Fund (the “Fund”), managed *553 from New York by Michael Berger (“Berger”). That Fund traded United States securities, and the plaintiffs allege that the Fund lost in excess of $400,000,000.

The plaintiffs sued, among others, the Bermuda accounting firm that served as the Fund’s auditor, Deloitte & Touche (Bermuda) (“DTB”), as well as the Swiss verein of which it was a member, Deloitte Touche Tohmatsu (“Deloitte”). After the claims against Deloitte were dismissed, fundamentally because the complaint failed sufficiently to allege Deloitte’s scienter, plaintiffs successfully moved to amend their complaint and reassert their action against Deloitte, based on a theory of agency.

Deloitte now moves for summary judgment on all claims against them. This motion addresses the extent to which De-loitte’s organized efforts at globalization make partners who are responsible for that effort its agents and thereby allow those partners’ scienter to be imputed to Deloitte. One of the individuals responsible for Deloitte’s globalization program was also the partner at DTB responsible for the Fund’s audit. Finding that the Cromer plaintiffs have raised questions of fact regarding whether that partner’s knowledge of the Fund’s audit was within the scope of his work as an agent of De-loitte, Deloitte’s motion is denied. Trial is scheduled for October 13, 2003.

Procedural History

To understand the context for this summary judgment motion, it is useful to describe two prior opinions in this action: the Opinion in 2001 dismissing Deloitte from this action, Cromer Finance Ltd. v. Berger, 137 F.Supp.2d 452, 498 (S.D.N.Y.2001) (“April 17 Opinion”), and the Opinion in 2002 granting leave to amend the pleadings and reassert claims against Deloitte, Cromer Finance Ltd. v. Berger, 2002 WL 826847, at *13 (S.D.N.Y. May 2, 2002) (“May 2 Opinion”). Each of these Opinions is described below and incorporated by reference.

Motion to Dismiss

Plaintiffs asserted eight causes of action against DTB in their original complaint: violation of Section 10(b) of the Securities Exchange Act (“Section 10(b)”), violation of Rule 10b-5, aiding and abetting common law fraud, aiding and abetting breach of fiduciary duty, common law fraud, gross negligence, negligence and professional malpractice. Plaintiffs brought all of these causes of action against Deloitte as well, adding a claim for violation of Section 20(a) of the Securities Exchange Act.

Plaintiffs’ claims against Deloitte were dismissed in the April 17 Opinion. The flaw in the case against Deloitte at that point in the litigation was primarily the failure of plaintiffs to allege adequately that Deloitte possessed the requisite scien-ter to be accountable under the various theories of recovery. Cromer, 137 F.Supp.2d at 493-96. To satisfy this scienter requirement within a claim of a Section 10(b) violation, plaintiffs must show either “(1) ... facts that constitute strong circumstantial evidence of conscious misbehavior or recklessness, or (2) allege facts to show that defendants had both motive and opportunity to commit fraud.” Id. at 468 (citation omitted). The complaint at that time was deficient in alleging these elements, as it relied on the presence of Deloitte’s name and logo on the audits to show Deloitte’s knowledge of the allegedly false information contained therein. The April 17 Opinion states:

The Complaint does not allege that [De-loitte] was even aware of the reports, much less aware that its name and logo were included on the audit reports.... The use of [Deloitte]’s name on the audit reports was undoubtedly of great im *554 portance to investors, providing a well-respected international organization’s imprimatur on the audits and lending credence to the work of a small, relatively unknown Bermuda entity. Nonetheless, the use of a defendant’s name on a document containing misleading information is, by itself, insufficient to constitute scienter.

Id. at 493-94. The lack of an allegation of actual or constructive knowledge on the part of Deloitte proved fatal to both causes of action under the Securities Exchange Act, the Section 20(a) claim, and the common law fraud claim. Id. at 494. The remainder of plaintiffs’ claims were dismissed for similar reasons: the requirement of “actual knowledge” to sustain claims of aiding and abetting common law fraud and aiding and abetting breach of fiduciary duty, and the need to show a “substantive communication” between De-loitte and investors to avoid dismissal of the negligence, gross negligence and malpractice claims. Id. at 495-96.

Motion to Amend

The May 2 Opinion granted plaintiffs’ motion to amend, whereby they repleaded their claims against Deloitte. Plaintiffs’ response to the need to allege scienter for Deloitte was to allege that William A. Jack (“Jack”), the DTB partner in charge of the Fund’s audits, was Deloitte’s agent during the performance of those audits. Plaintiffs alleged that Deloitte conveyed actual authority to Jack through his participation in Deloitte’s Global Financial Services Industries practice (“GFSI”), and because of this relationship, under agency law principles, any knowledge acquired by Jack in the course of this agency could be imputed to his principal. Cromer, 2002 WL 826847, at *2, *4. Finding that plaintiffs had adequately alleged the existence of an agency relationship, they were permitted to reassert their causes of action against De-loitte. 1 Discovery ensued and has concluded. Deloitte now moves for summary judgment.

BACKGROUND

The following facts are undisputed or as shown by the Cromer plaintiffs unless otherwise noted.

The Fund

The Fund was established in 1995, under the laws of the British Virgin Islands, and began trading United States securities in Spring 1996. As described in the Fund’s audit for the year ending December 31, 1996 (“1996 Audit”), the Fund was

designed to permit investors who are tax exempt United States investors or who are neither citizens or residents of the United States to participate in investments in a broad range of highly liquid listed securities, options and financial commodities.... Short sales are utilized when deemed appropriate.

The Fund lost money. Berger’s fraud was effectuated by manufacturing false monthly account statements through which he hid the Fund’s enormous losses.

DTB: The Fund’s Auditor

DTB submitted a proposal to Berger to serve as the Fund’s auditor by letter dated March 5, 1997. The letter is on stationery bearing the logos of both “Deloitte &

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Seggos v. Datre
E.D. New York, 2022
Rest. Law Ctr. v. City of N.Y.
360 F. Supp. 3d 192 (S.D. Illinois, 2019)
Meisel v. Grunberg
651 F. Supp. 2d 98 (S.D. New York, 2009)
Hotel 71 Mezz Lender LLC v. Falor
64 A.D.3d 430 (Appellate Division of the Supreme Court of New York, 2009)
CompuDyne Corp. v. Shane
453 F. Supp. 2d 807 (S.D. New York, 2006)

Cite This Page — Counsel Stack

Bluebook (online)
245 F. Supp. 2d 552, 2003 U.S. Dist. LEXIS 2249, 2003 WL 355440, Counsel Stack Legal Research, https://law.counselstack.com/opinion/cromer-finance-ltd-v-berger-nysd-2003.